reason report
bottom line increas convict new
power strong local market concentr brand
unleash leadership ceo gail boudreaux rais
yoy revenu growth line revis lt growth
guidanc provid cfo john gallina rais
ep reflect increas normal top line ep
growth guidanc see larg cap greatest
potenti posit earn revis growth acceler
multipl pois expand fundament
polici catalyst rais pt contempl price-to-earnings
averag ep
ingeniorx star show i-day beauti showcas
new integr model ingeniorx pbm deepti jain built
superior net cost rather legaci rebat driven model guarante
total cost outcom employ health medicar
medicaid custom base ingeniorx start on-board member
run-rat save mm funnel
market power provid final realiz need
employ primari care provid except gap-fil select market
comment paul marchetti head network point power
differenti local market concentr realiz total cost
structur improv realiz superior valu base
contract provid hospit health system appreci
last investor commun
reinvigor commerci busi commerci turnaround
well underway capabl leadership pete haytaian
execut vice presid presid commerci specialti
busi divis share gain revenu growth specialti
penetr top line growth mid upper-singl digit across risk
aso stop loss product margin expans
driven increas specialti penetr oper
effici underpin strong local market presenc
govern busi continu drive growth govern
segment felicia norwood expect grow low doubl digit
compound-annual-growth-rate normal margin medicar advantag
membership pois continu growth growth
individu group leverag commerci
share life valu proposit manag medicaid
ride tailwind secular growth privat complex
popul partnership non-antm blue prove synergist
compani inform svb leerink llc research
oper revenu billion number may add total due round
adjust ep number may add total due round
average ep
net debt total capit
price-to-earnings lt ep growth
year price history/av daili volume mil
pleas refer page analyst certif import disclosur price chart disclosur specif
cover compani statement valuat risk avail
dbg catalyst multipl expans diversifi
busi group dbg platform led prakash patel across high touch
caremor high aim healthcor servic
along ingeniorx expect drive revenu
focu integr product develop market
share gain within antm health plan segment third parti sale
realiz promis asset util
growth antm balanc sheet strong cfo expect
capit deploy tilt toward growth next year
previou emphasi share repurchas manag intend
dedic growth initi histor
rais estim reiter
consensu estim rais yoy revenu
growth line revis lt growth guidanc rais
ep reflect increas normal top line
ep growth guidanc
offer beat rais beyond offer acceler
growth expect ep beat rais posit
revis beyond act catalyst multipl expans
along delay new hh rebat rule end
comment period april delay hipf growth
acceler set continu next sever year make one
strongest convict idea broader servic coverag
rais pt contempl price-to-earnings averag
ep
increas convict new power strong local market
concentr brand unleash leadership ceo gail boudreaux rais
yoy revenu growth line revis lt growth guidanc
rais ep reflect increas normal top line ep
growth guidanc see larg cap greatest potenti posit
earn revis growth acceler multipl pois expand
fundament polici catalyst rais pt contempl price-to-earnings
averag ep
first day sinc showcas new gail boudreaux ceo c-
reiter consensu estim rais yoy revenu
growth line revis lt growth guidanc rais ep
reflect increas normal top line ep growth guidanc
reiter estim rais estim
offer beat rais
consensussvb leerinkconsensussvb leerinkconsensussvb incom non bp leerinkconsensusadjust fund membership insur membership membership revenu expens invest incom expens share count guidanc inc
day beauti showcas new integr model ingeniorx pbm
deepti jain built superior net cost rather legaci rebat driven model
guarante total cost outcom employ health medicar medicaid
custom base ingeniorx start on-board member next coupl month run-
rate save mm funnel bottom line back load
commerci save rest
third parti busi expect promis util final realiti ingenio
use expand servic exist client win back pharmaci busi
carv improv retent manag also go stand-alone pharmaci busi
aim creat new partnership non-anthem blue look pharmaci solut
pbm rebate-focus like tradit pbm formulari
consid drug cost effect overal health care cost member experi
addit introduc new integr medic rx spend guarante allow
predict transpar cost client regard transit manag
adam ensur member undergo smooth transit perform
comprehens test sinc guarante smooth cutov
ingeiorx abl better compet new landscap
ingeniorx start on-board member next coupl month run-rat save
 mm funnel bottom line back load commerci save
rest third parti busi expect promis
estim ep impact pbm save year
gross save gross save incom impact anthem inc
local market power provid final realiz need employ primari care
provid except gap file select market comment paul marchetti head
network point power differenti local market concentr realiz total
cost structur improv realiz superior valu base contract
provid hospit health system appreci last investor commun anthem
leverag commerci scale creat competit unit price parlay
govern busi claim system autom util
manag central use across busi line lead
also pioneer transit value-bas care array provid
collabor model arrang allow transpar increas data share
reduc administr expens provid manag project roughli doubl
amount spend risk share arrang expect gener approxim
anthem larg scale within market make prefer provid
lead movement value-bas
commerci turnaround well underway share gain revenu growth
specialti penetr expect membership growth across risk
aso top line growth mid upper-singl digit across risk aso stop loss product
margin expans driven increas specialti penetr
oper effici underpin strong local market presenc commerci busi
start see share gain improv local market execut coordin center
excel leverag effici drive systemat underwrit sale process
growth opportun commerci busi
deep network discount improv medic cost caus fee membership grow
market share gain past five year margin standpoint current
self-fund member equal fulli insur commerci member manag hope
narrow gap next year ingenio rx aid effort biggest driver
differ pharmaci retent rate improv buy-up ancillari servic
product expect close gap well
within specialti offer dental vision repres premium across anthem
core market current penetr rate low improv
penetr rate manag target low dd growth product would
industry-lead initi along addit new specialti product accident
ill hospit indemn etc set support turnaround commerci
increas penetr specialti differenti servic set aid growth
specialti buy-up could lead earn contribut year
earn contribut buy-up servicesrisk base earn contribut base earn contribut base buy opportun earn buy-up fee base member earn contribut contribut year inc
govern segment felicia norwood expect grow low doubl digit
compound-annual-growth-rate normal margin medicar advantag pois
continu growth membership growth individu group
leverag commerci share life valu proposit manag medicaid
ride tailwind secular growth privat complex popul
partnership non- blue prove synergist leverag oper excel
govern expertis blue local market knowledg provid network
see roughli medicaid opportun state transit remain portion
medicaid member yet manag privat plan tend higher acuiti
complex member repres higher pmpm opportun next year
project complex special popul repres total medicaid
busi today
increment opportun mix shift power medicaid growth
manag aim leverag cross shield strong brand local market expertis
nation scale oper prowess gain market share medicaid recent
partnership prove success nc link mn la past year
industry-lead win rate contract procur process
manag hope add leverag key asset caremor well
pbm offer ingeniorx
strength bcb partnership drive share gain medicaid
see medicaid pipelin
continu growth
medicar spend expect spend per recent estim
feder govern manag see signific opportun grow busi enrol
grow rapid pace guidanc assum growth greater
full suit product hmo ppo supplement benefit portfolio recent
ink partnership over-the-counter medicin set stage strong share gain
manag hope leverag larg base commerci client medicar servic
medicar wrap product increas penetr group market expect
grow group enrol almost member scale busi
significantli see revenu opportun target margin profil
rang
pipelin opportun await group retire market
leverag footprint dual elig
opportun medicar includ dual elig expect total
medicar beneficiari partner non-anthem blue gain access local market
similar medicaid broader particip medicar part stand-alone part
program new pbm offer
medicar opportun support growth
diversifi busi group dbg platform led prakash patel across high touch
caremor high aim healthcor servic expect reach
dbg ingeniorx expect drive revenu focu
integr product develop market share gain within antm health plan segment
third parti sale realiz promis asset util
dbg focus whole person lifetim integr
dbg form focu whole person lifetim integr care high touch care deliveri
asset caremor supplement high tech analyt solut aim specialti
core
dbg ultim goal provid continu care member particularli member
chronic complex condit account healthcar spend reduc gap
coverag lead high cost clinic event dr patel laid present
chronic member often get caught bermuda triangl healthcar poor
coordin home hospit nurs center dbg intend transform
model care whole person close integr three independ
interrel busi unit clinic pathway aim specialti health care deliveri
though caremor advanc analyt healthcor dbg remain payor-
agnost seek gener revenu third parti plan addit improv cost
qualiti outcom member eventu promis becom util
concert pbm ingeniorx
caremor close integr better provid high-touch end-to-end
clinic servic primari care end-of-lif care caremor antm integr health plan
deliveri system reli high-touch care model includ extensivist neighborhood
care center coordin care complex popul recent acquir focus
palli end-of life care caremor wrap around exist provid
network support primari care provid manag chronic condit
model reli pcp extensivist neighborhood center keep cost
member
aim healthcor dbg integr robust analyt care deliveri platform
better measur safeti best practic outcom aim evidence-bas approach
optim deliveri right amount care cost effect set aim focus
build touch point caremor funnel potenti patient
community-bas palli care set also touch point ingeniorx caremor
balanc sheet strong cfo allow pursu growth initi
year come capit deploy tilt toward growth next year
previou emphasi share repurchas manag intend dedic
core growth histor share buy back hand repres less
share wallet fall next year histor dividend
remain rel constant
capit deploy tilt toward growth initi year
refocus capit deploy growth initi compani
ep compound-annual-growth-rate come core growth oppos capit deploy
 front manag intend opportunist seek acquir tuck-in
acquisit synergist strateg focu view tuck-in vein health
sun america first choic like also like make acquisit build
dbg group manag focus asset seamlessli integr
specif expertis social determin transit care home set complex chronic
popul uniqu reimburs model
offer beat rais beyond offer acceler growth expect ep beat
rais posit revis beyond act catalyst multipl
expans along delay new hh rebat rule end comment
period april delay hipf growth acceler continu next sever
year make one strongest convict idea broader servic coverag
rais pt contempl price-to-earnings averag ep
valuat vs peer compel given growth outlook
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform
dcf valuat leverag forward forecast wacc termin growth rate
inform potenti multipl expans along sector compani specif catalyst
expect greater potenti multipl expans dcf valuat point significantli
upsid peer current trade level free cash flow yield ratio also inform
potenti multipl expans except low ratio and/or high free cash flow yield
point potenti greater multipl expans
pt contempl price-to-earnings averag ep
risk invest thesi valuat
legisl regulatori polici chang could either dis-intermedi
insur us benefit marketplac place unforeseen top-lin margin
headwind commerci medicar advantag medicaid dual elig book
not-for-profit health insur price irrat commerci health benefit
acceler employ exit sponsorship health benefit us
marketplac post implement afford act
advers select public exchang protect adequ given delay
true-up govern payment
acquisit asset without attract return capit investor
organiz and/or oper risk drive execut mis-step downsid risk
earn
primari valuat methodolog base absolut price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform dcf valuat
leverag forward forecast wacc termin growth rate inform
potenti multipl expans along sector compani specif catalyst expect
greater potenti multipl expans dcf valuat point significantli upsid
peer current trade level free cash flow yield ratio also inform
potenti multipl expans except low ratio and/or high free cash flow yield
point potenti greater multipl expans
price target base price-to-earnings averag ep
non-profit bcb plan insur price irrat commerci market rapidli
medic cost trend come higher anticip potenti econom downturn
provid re-up intens servic deliveri cobra acceler uptak
member util care advanc layoff pandem
employ exit rapidli sponsorship health benefit combat medic cost
inflat catalyz econom downturn
risk declin invest yield invest impair
state-bas actuari rate review limit sound price underwrit caus
longer term state-bas insur exchang advers select reduc
sustain earn power employ dump employe health insur
exchang signific margin compress potenti downsid membership
polit shock lead singl payer
compani specif risk signific declin equiti market could result increas fund
compani pension oblig polit legal oper regulatori econom
risk foreign oper
integr regulatori risk across merg ci esrx
dcf valuat leverag forward forecast wacc termin growth rate
inform potenti multipl expans along sector compani specif catalyst
expect greater potenti multipl expans dcf valuat point significantli
upsid peer current trade level free cash flow yield ratio also inform
potenti multipl expans except low ratio and/or high free cash flow yield
point potenti greater multipl expans price target base case
ep estim
risk valuat includ
start-up cost underwrit issu associ new busi on-board
particularli challeng new popul dual elig
annual off-cycl rate chang state medicaid program
uncertainti associ competit bid process state
legisl regulatori judici polici chang medicaid entitl program
state feder suprem court level also risk consid
pt contempl price-to-earnings averag ep
expect synergi across administr effici retail steerag aet member
benefit design chang floor rebat reduct store base distribut
 part polici drive upsid estim also multipl expans pt
underwrit risk aet asset trade peak margin commerci fulli
insur though medacorp commerci broker price survey give us confid
price environ remain appropri hard offer flat even potenti
modestli expand underwrit margin risk potenti futur margin compress
aet health insur even meaning given associ neg impact
debt ebitda load compani need focus debt
pay next month departur shawn guertin aet cfo
slate becom cfo make us less confid price postur
health insur book commenc new bulk compet
share gain commerci medicar advantag market
macroeconom risk risk macroeconom downturn higher
defens pbm sub sector given cyclic correl retail front store
sale employ data
regulatori risk convinc pbm add valu earn
low probabl threat potenti drug manufactur rebat elimin off-set
new busi model includ administr fee and/or perform guarante
expos pbm retail pharmaci busi compar
player pbm risk
execut integr risk face greater risk well given integr
pbm broader organ also transform agenda around
build retail front model amid risk leverag balanc sheet
e-commerce/amzn greater exposur eros sale on-line
channel well given exposur retail front store retail pharmaci e-
commerc though larg price retail multipl expect less like
pursu agenda becom pbm given associ integr clinic evid
base treatment guidelin integr provid network domin captiv pbm
model mega deal
remain posit reiter op rate month pt
contempl price-to-earnings averag ep
risk invest thesi valuat legisl regulatori
polici chang could either dis-intermedi health insur us benefit
marketplac place unforeseen top-lin margin headwind commerci medicar
advantag medicaid dual elig book busi not-for-profit health insur
price irrat commerci health benefit marketplac acceler employ exit
sponsorship health benefit us marketplac post implement
afford act advers select public exchang protect adequ
given delay true-up govern payment acquisit asset
without attract return capit investor organiz and/or oper risk
lead execut mis-step downsid risk earn acceler medic cost trend
util improv economi servic arena yet yield adequ
return capit
pt base sum-of-the-part sotp analysi
start-up cost underwrit issu associ new busi on-board
particularli challeng new popul dual elig
annual off-cycl rate chang state medicaid program
uncertainti associ competit bid process state
legisl regulatori judici polici chang medicaid
scale issu result loss specialti rx pharmaci contract
acquisit offer adequ return capit
upsid takeout substanti premium key risk
carve-out behavior health servic current state contract
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform
dcf valuat leverag forward forecast wacc termin growth rate
inform potenti multipl expans along sector compani specif catalyst
expect greater potenti multipl expans dcf valuat point significantli
upsid peer current trade level
free cash flow yield ratio also inform potenti multipl expans
except low ratio and/or high free cash flow yield point potenti greater
base post month turnaround rate outperform pt
contempl price-to-earnings averag
risk highlight first spike util on-board new state contract
dual elig integr second state-bas insur exchang result advers
select reduc sustain earn power third state-bas contract rate increas
suffici cover medic trend off-set industri fee medicaid premium fourth risk re-
procur exist contract could creat substanti downsid risk volatil fifth
legisl judici risk manag medicaid entitl extrem case singl
payer model also possibl downsid
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform
dcf valuat leverag forward forecast wacc termin growth rate
inform potenti multipl expans along sector compani specif catalyst
expect greater potenti multipl expans dcf valuat point significantli
upsid peer current trade level
free cash flow yield ratio also inform potenti multipl expans
except low ratio and/or high free cash flow yield point potenti greater
rate outperform price target contempl price-to-earnings
averag cash ep
non-profit bcb plan insur price irrat commerci market rapidli
medic cost trend come higher anticip potenti double-dip recess
provid re-up intens servic deliveri cobra acceler uptak member util
care advanc lay-off pandem
employ exit rapidli sponsorship health benefit combat medic cost
inflat catalyz double-dip recess
risk declin invest yield invest impair
state-bas actuari rate review limit sound price underwrit caus substanti
long-term state base health insur exchang advers select reduc
sustain earn power employ dump employe health insur
exchang signific margin compress also potenti downsid membership
risk relat collect industri fee medicar medicaid premium
polit shock lead singl payer
compani specif risk downsid risk price target includ acquisit asset
arena yield adequ return capit
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform
dcf valuat leverag forward forecast wacc termin growth rate
inform potenti multipl expans along sector compani specif catalyst
expect greater potenti multipl expans dcf valuat point significantli
upsid peer current trade level
free yield ratio also inform potenti multipl expans
except low ratio and/or high free yield point potenti greater
base rate wcg outperform pt contempl price-to-earnings
averag ep
downsid risk price target includ execut new state contract dual elig
award rate increas suffici cover medic trend state clawback tax off-set tax
reform tailwind potenti dial medicaid expans ky upsid risk price
target includ take-out larger player
anthem inc incom oper expensesbenefit oper invest incom extinguish incom continu incom chang revenu sg ratio oper revenu exclud intang amort exclud agp inc
enrol group self group fulli inc
